Press Release Issued:
IASIC Opposes the Removal of Cannabis from Schedule 1
BURLINGTON, Vermont – June 25, 2024 – The International Academy on the Science and Impact of Cannabis (IASIC) released its official statement against the proposed rescheduling of Cannabis from Schedule I to Schedule III of the Controlled Substances Act:
As physicians and concerned citizens of the United States of America, the International Academy on the Science and Impact of Cannabis believes that re-scheduling will have immediate and irreparable harm to the public health and vehemently oppose the removal of cannabis from Schedule 1. Specific objections include (1) The Department of Health and Human Services (HHS) inappropriately changed the definition of currently acceptable medical use (CAMU); (2) Even under the new definition, cannabis still does not meet the requirements for CAMU; (3) Proper regulation of cannabis as a schedule 3 drug cannot be achieved while non-medical cannabis commerce is allowed.
“HHS and those who are pushing rescheduling of cannabis are unaware or ignoring the huge amount of science on the medical harms of cannabis. There is zero benefit and only problems to be had from rescheduling,” said Eric A. Voth, MD, FACP, President and Chairman of the Board, The International Academy on the Science and Impact of Cannabis.
An official request for a hearing with the DEA has been submitted by IASIC during the current open comment period, with its leadership urging the presentation of medical and scientific research from its physician-driven organization of international experts on cannabis.
IASIC has provided substantial education and background on the impending harm of the proposed rescheduling in its monthly speaker series on June 11th as well as on the High Truths on Drugs and Addiction podcast with episode #182: High Truths on Drugs and Addiction on Rescheduling of Marijuana with IASIC.
IASIC Press Conference – 5/30/21: Doctors Warn – Cannabis Can Cause Serious Health Hazards
Colorado family blames high-potency marijuana for son’s suicide, urges lawmakers to look at impact of dabbing
Nearly nine years after voters legalized recreational marijuana in Colorado, one family is asking lawmakers to look closer at the impacts high-potency marijuana is having on the state. View the full article HERE
Overdose deaths far outpace COVID-19 deaths in San Francisco
A record 621 people died of drug overdoses in San Francisco so far this year, a staggering number that far outpaces the 173 deaths from COVID-19 the city has seen thus far. https://abcnews.go.com/Health/wireStory/overdose-deaths-outpace-covid-19-deaths-san-francisco-74823530
UCSD Study: Docs Should Screen For Cannabis Use Disorder in Pregnant Women
Women diagnosed with cannabis use disorder had babies who were more likely to be born preterm, have a low birth weight and be small for their gestational age — all factors that can require greater or more intense medical care or presage later health issues. https://www.nbcsandiego.com/news/local/ucsd-study-docs-should-screen-for-cannabis-use-disorder-in-pregnant-women/2584996/
Dr. Ken Finn, Editor of first textbook of Marijuana and IASIC founder talks science in Alabama.
Marijuana implicated in murder of 3 kids by mother
“Depressed” mom Liliana Carrillo who ‘killed 3 kids under 5 was suicidal & medicated with weed’ after dad warned cops Learn about marijuana-induced psychosis. https://www.the-sun.com/news/2696888/liliana-carrillo-killied-3-kids-suicidal/
Young people (up to age 25) who use marijuana are 4-7 times more likely than adults to develop a drug problem.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219953/
9% of those who experiment with marijuana will become addicted. 17% of teenagers who experiment with marijuana become addicted. 25-50% of daily users become addicted.
https://jamanetwork.com/journals/jama/article-abstract/379036
3 out of 10 cannabis users developed DSM IV Criteria of cannabis use disorder 19.5% of lifetime users met criteria for DSM 5 CUD of whom 23% have severe symptoms and of those 48% were not functioning (not working).
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5719106/
Listen to podcast High Truths on Drugs and Addiction on your favorite platform. Hightruth.com
Most Recent News
IASIC Speaker Series Presents: Impacts of Maternal Cannabis Use on Long-Term Psychiatric Risk
The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed,
Libby Stuyt Interview on Randy Tobler show
Exciting News! Libby Stuyt’s Interview on Randy Tobler Show! Hey everyone, we wanted to share some thrilling news! The brilliant Dr. Libby Stuyt recently had an enlightening interview on Randy Tobler Show. Dr. Stuyt is known for her groundbreaking work in the field of addiction medicine and mental health. Her insights are nothing short of
Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies
Introduction Cannabis contains over 100 cannabinoids, of which Δ9-tetrahydrocannabinol and cannabidiol are the most clinically relevant. Tetrahydrocannabinol is a partial agonist at CB1 and binds CB2 receptors. CB1 is widely expressed by central and peripheral neurones but also by immune cells and other type of cells in the brain and in the periphery, and when
IASIC Speaker Series Presents: Case Report on Cannabis-Induced Acute Encephalopathy in Elderly After Taking CBD
The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed,